IL6 and hypertriglyceridemia: Hypertriglyceridemia promotes a state of low-grade systemic inflammation, characterized by an increase in proinflammatory cytokines, such as interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and C-reactive protein (CRP) [49].